Additionally, anoikis-related genes such as ACTG1, STAT1, and CCR7 have been identified as biomarkers for cirrhosis, providing insights into the disease’s immune landscape and potential for targeted therapies [34]. This evidence concerns the gene STAT1 and Cirrhosis.